Breast Cancer

CLINICAL_TRIALS trial_result · 2024-08-07

Clinical Trial Update: Effect of Education on Breast Cancer Fear and Health Beliefs [NA]

This clinical trial assessed whether an educational program reduces fear of breast cancer and improves health beliefs among women. The study…

CLINICAL_TRIALS trial_result · 2024-08-07

Clinical Trial Update: Smart VR Mindfulness for Breast Cancer: Integrating Biofeedback and Evaluating Chemotherapy Effectiveness [NA]

Ongoing trial investigating smart VR mindfulness with biofeedback to support breast cancer patients during chemotherapy; the study is curren…

CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer [Phase 1, Phase 2]

This clinical trial update reports the termination of the Phase 1/2 study QUILT-3.040 evaluating ETBX-011 vaccine in combination with ALT-80…

CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: Measuring and Improving the Safety of Test Result Follow-Up [NA]

This clinical trial update reports the completion and posting of results for a study assessing methods to measure and improve safety in the …

CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer

This clinical trial update reports on an MRI-based multi-parametric model to early predict pathological complete response in breast cancer p…

CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: Effect of Intravenous S-ketamine on Opioid Consumption [NA]

A clinical trial update indicates the completion of a study evaluating intravenous S-ketamine for reducing opioid consumption after breast c…

CLINICAL_TRIALS trial_result · 2024-08-05

Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer [Phase 1]

Phase 1 study reporting safety, tolerability, and pharmacokinetics of DHES0815A in HER2-positive breast cancer, with results posted after co…

CLINICAL_TRIALS trial_result · 2024-08-05

Clinical Trial Update: RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

Clinical trial update for the RADIOSO MILAN I study, evaluating the RADar Reflector localization-SCOUT system for breast cancer, currently r…

CLINICAL_TRIALS trial_result · 2024-08-02

Clinical Trial Update: Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole [Phase 2]

Phase 2 neoadjuvant trial evaluating ribociclib with letrozole in locally advanced, ER-positive, HER2-negative breast cancer has completed.

CLINICAL_TRIALS trial_result · 2024-08-02

Clinical Trial Update: HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy [Phase 1]

This update reports the completion of a Phase 1 trial evaluating a HER-2 pulsed dendritic cell vaccine to prevent recurrence of invasive bre…

CLINICAL_TRIALS trial_result · 2024-08-02

Clinical Trial Update: Biofeedback Training on Shoulder Muscles Strength Post Mastectomy [NA]

A completed Cairo University–sponsored clinical trial evaluated whether biofeedback training can improve shoulder muscle strength after mast…

CLINICAL_TRIALS trial_result · 2024-08-02

Clinical Trial Update: Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer [NA]

A completed longitudinal clinical trial update examining behavioral, economic, and sociological outcomes after cancer, covering breast cance…

CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) [Phase 3]

Phase 3 trial evaluating trilaciclib in combination with gemcitabine and carboplatin for metastatic triple-negative breast cancer has comple…

CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant [Phase 3]

Phase 3 trial update evaluating molecular features in postmenopausal women with HR+/HER2-negative advanced breast cancer treated first-line …

CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast [Phase 1]

Phase 1 study evaluating safety and tolerability of combining Niraparib with Everolimus in advanced gynecologic malignancies and breast canc…

CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer [Phase 3]

A Phase 3 clinical trial evaluating GM1 prophylaxis to prevent chemotherapy-induced cognitive impairment in patients with early operable bre…

CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: GM1 Prophylaxis for WBRT Related Cognitive Dysfunction [Phase 3]

A Phase 3 trial evaluating GM1 ganglioside prophylaxis to prevent whole-brain radiotherapy-related cognitive dysfunction in patients with br…